Skip to main content
. 2020 Aug 4;324(5):471–480. doi: 10.1001/jama.2020.10224

Figure 4. Primary, Secondary, and Nonprespecified and Post Hoc Outcomes.

Figure 4.

To convert 25-hydroxyvitamin D to nmol/L, multiply by 2.5. The analyses were not adjusted for multiple comparisons. MET indicates metabolic equivalent task; VITAL-DEP, Vitamin D and Omega-3 Trial-Depression Endpoint Prevention.

aCalculated using Cox regression models that were controlled for age, sex, and fish oil group. For the subgroup analyses, the interactions were tested using multiplicative interaction terms.

bSum of incidence and recurrence of depression or clinically relevant depressive symptoms.

cAmong the 16 657 participants without a history of depression at baseline.

dAmong the 1696 participants with a history of depression at baseline who were not receiving treatment within the past 2 years.

eIncludes Hispanic, Asian/Pacific Islander, Native American/Alaskan Native, and other or multiple or unspecified race/ethnicity.

fRestricted to 800 IU/d or less from all sources combined (individual supplements and multivitamins).

gCalculated as weight in kilograms divided by height in meters squared.